Quisisana Hospital, Ferrara.
Department of Haematology, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Sultanate of Oman.
Acta Biomed. 2023 Oct 17;94(5):e2023225. doi: 10.23750/abm.v94i6.14909.
With the rising prevalence of obesity worldwide, it is becoming imperative to detect disturbed glucose metabolism as early as possible in order to prevent type 2 diabetes (T2D) development.
The present retrospective observational study aimed to evaluate the relationship between BMI and glucose metabolism, insulin secretion and sensitivity indices, derived from glucose tolerance test (OGTT), in β -TM female patients who were overweight (BMI 25-29.9 kg/m2) and follow its outcome over time.
Eleven overweight and 11 females with ideal weight and β -TM, matched for age, were recruited. OGTT was undertaken and different indices for β-cell function, insulin sensitivity and insulin secretion were calculated.
At first evaluation, 7 of 11 overweight β -TM patients (63.6%) and 3 of 11 normal weight β-TM patients (27.2%) had glucose dysregulation (GD) during OGTT. Overweight patients with β-TM had increased HOMA-IR and QUICKI indices associated with decreased Matsuda WBISI index. The mean ± SD duration of follow-up was 4.5 ± 1.2 years. At last observation, 2/11 overweight patients had developed T2D (18.1%). In patients with normal weight, GD increased from 3/11 (27.2%) to 5/11 (45.4%), but none developed T2DM. The difference between SF at first and last observation (1,220 ± 702 vs.1,091 ± 454 ng/mL; P: 0.61) was not significant.
Overweight seems to be an additional risk factor for the development of GD in β-TM patients. This is particularly important in clinical practice, due to the lack of appropriate guidelines dedicated to this group of patients.
随着全球肥胖患病率的上升,尽早发现葡萄糖代谢紊乱以预防 2 型糖尿病(T2D)的发生变得至关重要。
本回顾性观察研究旨在评估超重(BMI 25-29.9kg/m2)β-地中海贫血患者的 BMI 与葡萄糖代谢、胰岛素分泌和敏感性指数之间的关系,并观察其随时间的变化。
共招募了 11 名超重和 11 名体重指数正常且患有β-地中海贫血的女性患者,这些患者按年龄匹配。进行口服葡萄糖耐量试验(OGTT),并计算不同的β细胞功能、胰岛素敏感性和胰岛素分泌指数。
在首次评估时,11 名超重β-地中海贫血患者中有 7 名(63.6%)和 11 名体重指数正常的β-地中海贫血患者中有 3 名(27.2%)在 OGTT 期间出现葡萄糖调节受损(GD)。超重的β-地中海贫血患者的 HOMA-IR 和 QUICKI 指数增加,而 Matsuda WBISI 指数降低。平均随访时间为 4.5±1.2 年。最后观察时,有 2/11 名超重患者发展为 T2D(18.1%)。在体重指数正常的患者中,GD 从 3/11(27.2%)增加到 5/11(45.4%),但没有患者发展为 T2DM。首次和最后观察时 SF 的差异(1,220±702 与 1,091±454ng/mL;P:0.61)无统计学意义。
超重似乎是β-地中海贫血患者发生 GD 的额外危险因素。这在临床实践中尤为重要,因为缺乏专门针对这组患者的适当指南。